These findings indicated that the crosstalk between Hippo pathway and EGFR signaling played a vital role in the carcinogenesis of multiple malignancies, combined targeting YAP and the EGFR signaling might represent a novel therapeutic strategy for the treatment of HCC, as well as several other cancers (Suppl. Here, EGFR is linked to hepatocellular carcinoma.